Aperio Group’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | $1.14M | Buy |
49,436
+585
| +1% | +$13.5K | ﹤0.01% | 1527 |
|
2020
Q3 | $690K | Buy |
48,851
+2,187
| +5% | +$30.9K | ﹤0.01% | 1636 |
|
2020
Q2 | $704K | Buy |
46,664
+5,138
| +12% | +$77.5K | ﹤0.01% | 1590 |
|
2020
Q1 | $384K | Sell |
41,526
-11,221
| -21% | -$104K | ﹤0.01% | 1785 |
|
2019
Q4 | $514K | Buy |
52,747
+26,596
| +102% | +$259K | ﹤0.01% | 1783 |
|
2019
Q3 | $210K | Buy |
26,151
+389
| +2% | +$3.12K | ﹤0.01% | 2155 |
|
2019
Q2 | $322K | Buy |
25,762
+4,026
| +19% | +$50.3K | ﹤0.01% | 1992 |
|
2019
Q1 | $296K | Buy |
21,736
+1,525
| +8% | +$20.8K | ﹤0.01% | 2003 |
|
2018
Q4 | $194K | Buy |
20,211
+3,534
| +21% | +$33.9K | ﹤0.01% | 2134 |
|
2018
Q3 | $202K | Buy |
16,677
+1,323
| +9% | +$16K | ﹤0.01% | 2187 |
|
2018
Q2 | $240K | Sell |
15,354
-396
| -3% | -$6.19K | ﹤0.01% | 2092 |
|
2018
Q1 | $237K | Buy |
15,750
+77
| +0.5% | +$1.16K | ﹤0.01% | 2063 |
|
2017
Q4 | $226K | Buy |
15,673
+347
| +2% | +$5K | ﹤0.01% | 2096 |
|
2017
Q3 | $231K | Buy |
15,326
+1,340
| +10% | +$20.2K | ﹤0.01% | 2058 |
|
2017
Q2 | $141K | Buy |
13,986
+1,663
| +13% | +$16.8K | ﹤0.01% | 2149 |
|
2017
Q1 | $88K | Buy |
+12,323
| New | +$88K | ﹤0.01% | 2116 |
|